Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 11, 2021, titled "Sun Pharma geared to introduce Molnupiravir, licensed from MSD and Ridgeback, under the brand name Molxvir�� in India".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 11, 2021, titled "Sun Pharma geared to introduce Molnupiravir, licensed from MSD and Ridgeback, under the brand name Molxvir�� in India".